ALKAHEST INC. / GRIFOLS SA / Private / Minority / Acquisition / £26m

Synopsis

Sale of a 45% stake of Alkahest, a biotechnology company providing initiation clinical trials for Alzheimer’s patients, to Grifols.

Principals

Alkahest

Grifols

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

charles hoyng

Latham & Watkins

Lawyer

target

Deal

£ 12 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy